Unknown

Dataset Information

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty.


ABSTRACT:

Background

Effective therapeutic management of elderly patients with cancer, on an individual basis, remains a clinical challenge. Here, we identify novel biomarkers to assess elderly patients (≥70 years of age) with breast cancer undergoing treatment with or without chemotherapy.

Methods

We performed comprehensive geriatric assessment and measured markers sensitive to alteration in ageing, including leukocyte telomere length, CMV serostatus, levels of circulating growth factors and cytokines, and immune profiling of T cell and myeloid populations in blood before and at 3 months and 12 months after initiation of therapy, using flow cytometry.

Results

We observed changes in immune profiles over time that were specific to patients receiving chemotherapy; these patients

SUBMITTER: Bailur JK 

PROVIDER: S-EPMC5330012 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature